Archive
New articles published by Gut Pathogens
High dietary zinc supplementation increases the occurrence of tetracycline and sulfonamide resistance genes in the intestine of weaned pigs Wilfried Vahjen, Dominika Pietruszyńska, Ingo Starke, Jürgen Zentek Gut Pathogens 2015, 7:23 (26 August 2015)
Interaction of caffeine with the SOS response pathway in Escherichia coli Alyssa K Whitney, Tiffany L Weir Gut Pathogens 2015, 7:21 (18 August 2015)
Genome architecture of Lactobacillus plantarum PS128, a probiotic strain with potential immunomodulatory activity Wei-Hsien Liu, Chih-Hsien Yang, Ching-Ting Lin, Shiao-Wen Li, Wei-Shen Cheng, Yi-Ping Jiang, Chien-Chen Wu, Chuan-Hsiung Chang, Ying-Chieh Tsai Gut Pathogens 2015, 7:22 (15 August 2015)
New articles published in Gut Pathogens
MGEN launched with Open Data policy
An elaborate and extensive data sharing and archiving policy and a plausible partnership with Figshare is what makes MGEN a unique platform. We at GutPathogens are also contemplating to form a similarly elaborate and explicit policy for the Genome Reports (formerly the ‘genome announcements’) being published by the latter.
Narender’s pre-PhD defense seminar on April 10
Narender Kumar will defend his PhD work on April 10, 2015 at 12.00 Noon at the Seminar Room, School of Life Sciences, University of Hyderabad. All are invited. Hot samosas and cool drinks will be on us.
Refer to Narens’ work here..
(In pic: Narender Kumar with Prof. Barry J Marshall, Nobelist of 2005).
New thematic series in Gut Pathogens: Probiotics and Metagenomics of gut pathogens
Gut Pathogens is delighted to introduce two new thematic series, highlighting articles published in the journal on the topics of Probiotics and Metagenomic analysis of gut pathogens. These new article collections are currently open for submissions on all aspects of probiotic research and metagenomic analysis of gut microbes.
Probiotics is a term used to describe any micro-organism which has a beneficial impact on another organism. There has been extensive research into probiotics and their health implications, and Gut Pathogens is excited to introduce a new article collection highlighting the latest research in this area. The series brings together a variety of original research and review articles discussing the topics of new trends and future prospects for probiotics, health implications, probiotic use for treating disease, and their effect on mental health.
The series includes a timely review of the approaches currently being used and developed to identify probiotic species of the genus Lactobacillus. Herbel et al., compare multiple tools and techniques, including Whole Genome Sequencing and real time PCR, used for identifying probiotic bacterial strains and give an informed prediction of future in this area. A recent piece of original research published in this series investigates the use of the probiotic Lactobacillus rhamnosus GG (LGG) in the treatment of Human rotavirus (HRV), the most common cause of severe diarrhoea in infants and young children. The authors discovered that LGG treatment induced cell death and partially prevented virus-induced tissue damage, providing a promising outlook for the probiotic treatment of HRV.
Genomic analysis of gastrointestinal tract pathogens is key to understanding them and could potentially lead to the development of therapeutics, including probiotics, against them. To showcase the latest research in all aspects of metagenomics of gut pathogens and microbiota, a special series has been introduced.
A fascinating piece of original research by Monira et al., published in this series investigates the metagenomic profile of gut microbiota in children during cholera and recovery. This article gives an important insight into the possibility of post-cholera intervention to promote the restoration of the gut environment. Another interesting research article in this series explores the differences in gut microbiota composition between obese and lean children. This may lead to the development of new approaches to managing childhood obesity and associated disorders.
These new article collections are currently open for submissions on all aspects of probiotic research and metagenomic analysis of gut microbes. For more information on submitting to these article series, please visit the journal website or contact editorial@gutpathogens.com.
Jennifer Franklin
Journal Development Editor
Gut Pathogens calling for your Genome Announcements
Gut Pathogens is now accepting submissions of Genome Announcements – articles giving a brief and concise account of a complete or partial genome of a gut pathogen or probiotic organism.
Gut Pathogens, which received an Impact Factor of 2.11 this year, is truly an international journal and the ideal forum for the rapid and global dissemination of your Genome Announcement. The open access platform allows for greater visibility and the average time from submission to first decision is just 15 days.
Co-Editor-in-Chief, Professor Niyaz Ahmed, envisages the journal becoming ‘a single, specialized publication dedicated to covering both the biology and clinical microbiology of major bacterial and viral pathogens of threat to gut health.’
In addition, he foresees Gut Pathogens becoming a single niche journal for both the biology of probiotics and probiotic-interventions against pathogens.
Submit your Genome Announcement to Gut Pathogens today!
Dr Srimathy Sriskantharajah
Senior Journal Development Editor